<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0013415" disease_type="Mental or Behavioral Dysfunction" abbrv="">Dysthymia</z:e> is a depressive <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">mood disorder</z:e> characterized by <z:hpo ids='HP_0011010'>chronic</z:hpo> and persistent but mild <z:hpo ids='HP_0000716'>depression</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It is often difficult to be distinguished from major <z:hpo ids='HP_0000716'>depression</z:hpo>, specifically in its partially remitted state because "<z:e sem="disease" ids="C0424091" disease_type="Mental or Behavioral Dysfunction" abbrv="">loss of interest</z:e>" or "<z:hpo ids='HP_0000741'>apathy</z:hpo>" tends to prevail both in <z:e sem="disease" ids="C0013415" disease_type="Mental or Behavioral Dysfunction" abbrv="">dysthymia</z:e>, and remitted <z:hpo ids='HP_0000716'>depression</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000741'>Apathy</z:hpo> may also occur in various psychiatric and <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e>, including <z:hpo ids='HP_0100753'>schizophrenia</z:hpo>, <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, <z:e sem="disease" ids="C0038868" disease_type="Disease or Syndrome" abbrv="PSNP1">progressive supranuclear palsy</z:e>, <z:e sem="disease" ids="C0020179" disease_type="Disease or Syndrome" abbrv="HD">Huntington's disease</z:e>, and <z:hpo ids='HP_0000726'>dementias</z:hpo> such as <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and <z:hpo ids='HP_0002145'>frontotemporal dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>It is symptomatologically important that <z:hpo ids='HP_0000741'>apathy</z:hpo> is related to, but different from, major <z:hpo ids='HP_0000716'>depression</z:hpo> from the viewpoint of its causes and treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Antidepressants, especially noradrenergic agents, are useful for <z:hpo ids='HP_0000716'>depression</z:hpo>-related <z:hpo ids='HP_0000741'>apathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>However, selective <z:chebi fb="19" ids="28790">serotonin</z:chebi> reuptake inhibitors (SSRIs) may be less effective for <z:hpo ids='HP_0000741'>apathy</z:hpo> in depressed elderly patients and have even been reported to worsen <z:hpo ids='HP_0000741'>apathy</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="51065">Dopaminergic agonists</z:chebi> seem to be effective for <z:hpo ids='HP_0000741'>apathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="38462">Acetylcholine esterase inhibitors</z:chebi>, <z:chebi fb="0" ids="6887">methylphenidate</z:chebi>, atypical <z:chebi fb="0" ids="35476">antipsychotics</z:chebi>, nicergoline, and cilostazol are another choice </plain></SENT>
<SENT sid="8" pm="."><plain>Medication choice should be determined according to the background and underlying etiology of the targeting disease </plain></SENT>
</text></document>